GSK plc risk profile
35 Normal where most of the sector sits
Measured 1 September 2026 from GS71's filed statements. Recomputed nightly.
35 (Normal), driven by Competitive position at 43, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 35 | Normal | Stable | One-year price volatility — 26.7% |
| Operating pressure | 25 | Normal | Easing | Operating-margin drift — +2.3 percentage points |
| Cash conversion | 25 | Normal | Worsening | Cash conversion — 1.23x |
| Leverage and coverage | Reads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company. | |||
| Competitive position | 43 | Elevated | Stable | Revenue-growth gap against peers — -18.6 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.